Trial Profile
A Patient Registry to Observe the Real-World Dosing and Titration of Tyvaso®
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors United Therapeutics Corporation
- 16 Oct 2015 New trial record